Neptune Wellness Solutions Inc.
Healthcare · Pharmaceutical Preparations · A8 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | |
|---|---|---|---|
| Revenue | $51.7M | $47.7M | $34.3M |
| Operating income | −$102.8M | −$88.5M | −$130.9M |
| Net income | −$60.5M | −$75.0M | −$123.2M |
| Total assets | $30.9M | $105.0M | $186.9M |
| Total liabilities | $58.5M | $44.1M | $49.4M |
| Equity | −$11.9M | $48.1M | $115.4M |
| EPS (diluted) | $-5.12 | $-15.54 | $-35.86 |
| Shares out. | 21.8M | 7.6M | 4.7M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −198.8%
- Net margin
- −116.8%
- Return on equity
- 506.4%
- Return on assets
- −195.5%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 189.1%
- Debt / equity
- —
- Book value / share
- $-0.55
- Revenue growth (YoY)
- 8.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -66.71distress
- Accruals / assets
- −103.1%clean
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 3 severe● 4 warning● 3 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Feb 15, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2023
- NT 10-Kmissed a reporting deadline ↗Jun 30, 2023
- NT 10-Qmissed a reporting deadline ↗Feb 15, 2023
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2022
- NT 10-K/Amissed a reporting deadline ↗Jul 1, 2022
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Neptune Securities Settlement Fund10% owner | Apr 24, 2024 | Sell | 100,300 | $0.07 |
| Neptune Securities Settlement Fund10% owner | Mar 1, 2024 | Sell | 64,819 | $0.44 |
| Neptune Securities Settlement Fund10% owner | Nov 28, 2023 | Sell | 29,129 | $0.70 |
| Neptune Securities Settlement Fund10% owner | Nov 22, 2023 | Sell | 3,938 | $0.73 |
| Neptune Securities Settlement Fund10% owner | Nov 13, 2023 | Sell | 613 | $0.70 |
| Neptune Securities Settlement Fund10% owner | Nov 8, 2023 | Sell | 28,079 | $0.71 |
| Neptune Securities Settlement Fund10% owner | Oct 23, 2023 | Sell | 6,988 | $0.80 |
| Neptune Securities Settlement Fund10% owner | Oct 17, 2023 | Sell | 63,000 | $1.09 |
| Cammarata MichaelOfficer — President and CEO | Dec 27, 2022 | Option exercise | 87,289 | — |
| Cammarata MichaelOfficer — President and CEO | Aug 17, 2022 | Option exercise | 174,580 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Director / officer changeMay 6, 2024
- Entered a material agreement · Completed an acquisition or dispositionApr 12, 2024
- Debt acceleration / triggering event · Director / officer changeMar 27, 2024
- Director / officer change · Other material eventMar 12, 2024
- Delisting / listing-standard notice · Regulation FD disclosureMar 6, 2024
- Director / officer change · Other material eventFeb 27, 2024
- Results of operationsFeb 20, 2024
- Delisting / listing-standard noticeDec 5, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KFORM 8-KMay 6, 2024
- 4PRIMARY DOCUMENTApr 30, 2024
- 25-NSEApr 25, 2024
- 8-KFORM 8-KApr 12, 2024
- 8-KFORM 8-KMar 27, 2024
- 8-KFORM 8-KMar 12, 2024
- 8-KFORM 8-KMar 6, 2024
- 4PRIMARY DOCUMENTMar 6, 2024
- 8-KFORM 8-KFeb 27, 2024
- 8-KFORM 8-KFeb 20, 2024
- 10-QFORM 10-QFeb 16, 2024
- NT 10-QFORM NT 10-QFeb 15, 2024
- SC 13G/AFeb 12, 2024
- SC 13G/ANEPT 14GA 1.02.24Jan 2, 2024
- 8-KFORM 8-KDec 5, 2023
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.